eXoZymes (EXOZ) Stock Chart & Stock Price History $9.31 -0.47 (-4.81%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock eXoZymes Stock Price Performance The eXoZymes (EXOZ) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 1.59%, reflecting recent market activity. As of the latest close, eXoZymes traded at $9.78 with a market cap of $82.05 million and volume of 1,905 shares. Receive EXOZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eXoZymes and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.02%1 Month Performance-1.59%3 Month Performance-38.55% EXOZ Stock Chart for Thursday, August, 21, 2025 EXOZ Chart by TradingView eXoZymes Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/20/2025$9.78$9.78$9.88$9.751,905 shs$82.05 million08/19/2025$9.76$9.78+0.20%$9.78$9.78465 shs$82.03 million08/18/2025$9.70$9.76+0.62%$10.00$9.702,697 shs$81.89 million08/15/2025$9.99$9.70-2.90%$9.85$9.70486 shs$81.38 million08/14/2025$9.99$9.99$10.06$9.992,415 shs$83.62 million08/13/2025$10.03$9.99-0.40%$10.06$9.992,415 shs$83.60 million08/12/2025$9.86$10.03+1.72%$10.03$9.88489 shs$83.95 million08/11/2025$9.84$9.86+0.20%$9.86$9.86274 shs$82.53 million08/08/2025$10.01$9.84-1.70%$10.02$9.681,174 shs$82.36 million08/07/2025$10.01$10.01$10.01$9.66744 shs$83.76 million Get the Latest News and Ratings for EXOZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eXoZymes and its competitors with MarketBeat's FREE daily newsletter. 08/06/2025$10.09$10.01-0.79%$10.01$9.66744 shs$83.78 million08/05/2025$9.94$10.09+1.51%$10.09$9.63538 shs$84.45 million08/04/2025$10.07$9.94-1.29%$9.94$9.841,392 shs$83.18 million08/01/2025$10.10$10.07-0.30%$10.08$9.801,060 shs$84.29 million07/31/2025$10.10$10.10$10.10$9.831,553 shs$84.52 million07/30/2025$10.12$10.10-0.20%$10.10$9.831,553 shs$84.54 million07/29/2025$9.93$10.12+1.91%$10.18$9.806,503 shs$84.70 million07/28/2025$9.98$9.93-0.50%$10.07$9.932,041 shs$83.09 million07/25/2025$9.95$9.98+0.30%$10.87$9.714,056 shs$83.51 million07/24/2025$9.50$9.95+4.74%$12.99$9.3136,869 shs$83.28 million07/23/2025$9.19$9.50+3.37%$9.68$9.176,573 shs$79.52 million07/22/2025$9.46$9.19-2.85%$9.42$9.0414,906 shs$76.90 million07/21/2025$9.25$9.46+2.27%$9.48$9.202,891 shs$79.18 million Related Companies Rocket Pharmaceuticals Stock Chart Altimmune Stock Chart Benitec Biopharma Stock Chart Aldeyra Therapeutics Stock Chart Candel Therapeutics Stock Chart Aurora Cannabis Stock Chart 4D Molecular Therapeutics Stock Chart Amarin Stock Chart DiaMedica Therapeutics Stock Chart Design Therapeutics Stock Chart Receive EXOZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eXoZymes and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EXOZ) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eXoZymes Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eXoZymes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access